Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23146679)

1.

DNA vaccine encoding the major virulence factors of Shiga toxin type 2e (Stx2e)-expressing Escherichia coli induces protection in mice.

Ren W, Yu R, Liu G, Li N, Peng Y, Wu M, Yin Y, Li Y, Fatufe AA, Li T.

Vaccine. 2013 Jan 2;31(2):367-72. doi: 10.1016/j.vaccine.2012.10.107. Epub 2012 Nov 10.

PMID:
23146679
2.

Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease.

Sato T, Matsui T, Takita E, Kadoyama Y, Makino S, Kato K, Sawada K, Hamabata T.

J Vet Med Sci. 2013 Oct;75(10):1309-15. Epub 2013 Jul 3.

3.

The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin.

Ran XQ, Wang HZ, Liu JJ, Li S, Wang JF.

Vet Microbiol. 2008 Feb 5;127(1-2):209-15. Epub 2007 Aug 19.

PMID:
17920213
5.

Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.

Gu J, Liu Y, Yu S, Wang H, Wang Q, Yi Y, Zhu F, Yu XJ, Zou Q, Mao X.

Microbes Infect. 2009 Sep;11(10-11):835-41. doi: 10.1016/j.micinf.2009.04.024. Epub 2009 May 7.

PMID:
19427397
6.

Transgenic lettuce producing a candidate protein for vaccine against edema disease.

Matsui T, Asao H, Ki M, Sawada K, Kato K.

Biosci Biotechnol Biochem. 2009 Jul;73(7):1628-34. Epub 2009 Jul 7.

7.

Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease.

Makino S, Watarai M, Tabuchi H, Shirahata T, Furuoka H, Kobayashi Y, Takeda Y.

Microb Pathog. 2001 Jul;31(1):1-8.

PMID:
11427031
8.

The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate.

Tiels P, Verdonck F, Coddens A, Goddeeris B, Cox E.

Vaccine. 2008 Apr 16;26(17):2154-63.

PMID:
18543416
9.

Production of double repeated B subunit of Shiga toxin 2e at high levels in transgenic lettuce plants as vaccine material for porcine edema disease.

Matsui T, Takita E, Sato T, Aizawa M, Ki M, Kadoyama Y, Hirano K, Kinjo S, Asao H, Kawamoto K, Kariya H, Makino S, Hamabata T, Sawada K, Kato K.

Transgenic Res. 2011 Aug;20(4):735-48. doi: 10.1007/s11248-010-9455-9. Epub 2010 Oct 24.

PMID:
20972886
10.
11.
12.

Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin.

Tsuji T, Shimizu T, Sasaki K, Shimizu Y, Tsukamoto K, Arimitsu H, Ochi S, Sugiyama S, Taniguchi K, Neri P, Mori H.

Vaccine. 2008 Jan 24;26(4):469-76. Epub 2007 Dec 3.

PMID:
18093704
13.

Evaluation of major types of Shiga toxin 2E-producing Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for humans.

Beutin L, Krüger U, Krause G, Miko A, Martin A, Strauch E.

Appl Environ Microbiol. 2008 Aug;74(15):4806-16. doi: 10.1128/AEM.00623-08. Epub 2008 May 30.

14.

Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.

Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S.

Infect Immun. 2007 Apr;75(4):1916-25. Epub 2006 Dec 4.

15.

Expression of verocytotoxic Escherichia coli antigens in tobacco seeds and evaluation of gut immunity after oral administration in mouse model.

Rossi L, Di Giancamillo A, Reggi S, Domeneghini C, Baldi A, Sala V, Dell'Orto V, Coddens A, Cox E, Fogher C.

J Vet Sci. 2013;14(3):263-70. Epub 2013 Jun 28.

16.

Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.

Zhang XH, He KW, Zhang SX, Lu WC, Zhao PD, Luan XT, Ye Q, Wen LB, Li B, Guo RL, Wang XM, Lv LX, Zhou JM, Yu ZY, Mao AH.

Vaccine. 2011 May 17;29(22):3923-9. doi: 10.1016/j.vaccine.2011.02.007. Epub 2011 Feb 21.

PMID:
21338683
17.
18.

Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development.

Cheng Y, Feng Y, Luo P, Gu J, Yu S, Zhang WJ, Liu YQ, Wang QX, Zou QM, Mao XH.

J Microbiol. 2009 Aug;47(4):498-505. doi: 10.1007/s12275-009-0116-8. Epub 2009 Sep 9.

PMID:
19763426
19.

Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.

Gu J, Ning Y, Wang H, Xiao D, Tang B, Luo P, Cheng Y, Jiang M, Li N, Zou Q, Mao X.

Vaccine. 2011 Oct 6;29(43):7395-403. doi: 10.1016/j.vaccine.2011.07.069. Epub 2011 Jul 30.

PMID:
21807051
20.

Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA.

Tiels P, Verdonck F, Coddens A, Ameloot P, Goddeeris B, Cox E.

Vet Microbiol. 2007 Jan 31;119(2-4):115-20. Epub 2006 Sep 10.

PMID:
17084564
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk